Global Placental Stem Cell Therapy Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Hematologic Malignancies and Disorders
  • 1.2.3 Congenital Immunodeficiency Disorders
  • 1.2.4 Metabolic Disorders
  • 1.2.5 Neurological Disorders
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Placental Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals and Specialty Clinics
  • 1.3.3 Clinical Research Organizations
  • 1.3.4 Research Institutes and Academies
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Placental Stem Cell Therapy Market Perspective (2016-2027)
• 2.2 Placental Stem Cell Therapy Growth Trends by Regions
  • 2.2.1 Placental Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Placental Stem Cell Therapy Historic Market Share by Regions (2016-2021)
  • 2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
• 2.3 Placental Stem Cell Therapy Industry Dynamic
  • 2.3.1 Placental Stem Cell Therapy Market Trends
  • 2.3.2 Placental Stem Cell Therapy Market Drivers
  • 2.3.3 Placental Stem Cell Therapy Market Challenges
  • 2.3.4 Placental Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Placental Stem Cell Therapy Players by Revenue
  • 3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2016-2021)
  • 3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2016-2021)
• 3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
• 3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
  • 3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2020
• 3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
• 3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
• 3.7 Date of Enter into Placental Stem Cell Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Placental Stem Cell Therapy Breakdown Data by Type

• 4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2016-2021)
• 4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Placental Stem Cell Therapy Breakdown Data by Application

• 5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2016-2021)
• 5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Placental Stem Cell Therapy Market Size (2016-2027)
• 6.2 North America Placental Stem Cell Therapy Market Size by Type
  • 6.2.1 North America Placental Stem Cell Therapy Market Size by Type (2016-2021)
  • 6.2.2 North America Placental Stem Cell Therapy Market Size by Type (2022-2027)
  • 6.2.3 North America Placental Stem Cell Therapy Market Size by Type (2016-2027)
• 6.3 North America Placental Stem Cell Therapy Market Size by Application
  • 6.3.1 North America Placental Stem Cell Therapy Market Size by Application (2016-2021)
  • 6.3.2 North America Placental Stem Cell Therapy Market Size by Application (2022-2027)
  • 6.3.3 North America Placental Stem Cell Therapy Market Size by Application (2016-2027)
• 6.4 North America Placental Stem Cell Therapy Market Size by Country
  • 6.4.1 North America Placental Stem Cell Therapy Market Size by Country (2016-2021)
  • 6.4.2 North America Placental Stem Cell Therapy Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Placental Stem Cell Therapy Market Size (2016-2027)
• 7.2 Europe Placental Stem Cell Therapy Market Size by Type
  • 7.2.1 Europe Placental Stem Cell Therapy Market Size by Type (2016-2021)
  • 7.2.2 Europe Placental Stem Cell Therapy Market Size by Type (2022-2027)
  • 7.2.3 Europe Placental Stem Cell Therapy Market Size by Type (2016-2027)
• 7.3 Europe Placental Stem Cell Therapy Market Size by Application
  • 7.3.1 Europe Placental Stem Cell Therapy Market Size by Application (2016-2021)
  • 7.3.2 Europe Placental Stem Cell Therapy Market Size by Application (2022-2027)
  • 7.3.3 Europe Placental Stem Cell Therapy Market Size by Application (2016-2027)
• 7.4 Europe Placental Stem Cell Therapy Market Size by Country
  • 7.4.1 Europe Placental Stem Cell Therapy Market Size by Country (2016-2021)
  • 7.4.2 Europe Placental Stem Cell Therapy Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2016-2027)
• 8.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type
  • 8.2.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application
  • 8.3.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
  • 8.4.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Placental Stem Cell Therapy Market Size (2016-2027)
• 9.2 Latin America Placental Stem Cell Therapy Market Size by Type
  • 9.2.1 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2021)
  • 9.2.2 Latin America Placental Stem Cell Therapy Market Size by Type (2022-2027)
  • 9.2.3 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2027)
• 9.3 Latin America Placental Stem Cell Therapy Market Size by Application
  • 9.3.1 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2021)
  • 9.3.2 Latin America Placental Stem Cell Therapy Market Size by Application (2022-2027)
  • 9.3.3 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2027)
• 9.4 Latin America Placental Stem Cell Therapy Market Size by Country
  • 9.4.1 Latin America Placental Stem Cell Therapy Market Size by Country (2016-2021)
  • 9.4.2 Latin America Placental Stem Cell Therapy Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2016-2027)
• 10.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type
  • 10.2.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application
  • 10.3.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
  • 10.4.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Lifebank Stem Cell Banking
  • 11.1.1 Lifebank Stem Cell Banking Company Details
  • 11.1.2 Lifebank Stem Cell Banking Business Overview
  • 11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
  • 11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.1.5 Lifebank Stem Cell Banking Recent Development
• 11.2 Cynata
  • 11.2.1 Cynata Company Details
  • 11.2.2 Cynata Business Overview
  • 11.2.3 Cynata Placental Stem Cell Therapy Introduction
  • 11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.2.5 Cynata Recent Development
• 11.3 Celularity
  • 11.3.1 Celularity Company Details
  • 11.3.2 Celularity Business Overview
  • 11.3.3 Celularity Placental Stem Cell Therapy Introduction
  • 11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.3.5 Celularity Recent Development
• 11.4 Athersys
  • 11.4.1 Athersys Company Details
  • 11.4.2 Athersys Business Overview
  • 11.4.3 Athersys Placental Stem Cell Therapy Introduction
  • 11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.4.5 Athersys Recent Development
• 11.5 Americord Registry
  • 11.5.1 Americord Registry Company Details
  • 11.5.2 Americord Registry Business Overview
  • 11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
  • 11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.5.5 Americord Registry Recent Development
• 11.6 ReNeuron Group
  • 11.6.1 ReNeuron Group Company Details
  • 11.6.2 ReNeuron Group Business Overview
  • 11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
  • 11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.6.5 ReNeuron Group Recent Development
• 11.7 ReeLabs
  • 11.7.1 ReeLabs Company Details
  • 11.7.2 ReeLabs Business Overview
  • 11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
  • 11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.7.5 ReeLabs Recent Development
• 11.8 Mesoblast
  • 11.8.1 Mesoblast Company Details
  • 11.8.2 Mesoblast Business Overview
  • 11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
  • 11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.8.5 Mesoblast Recent Development
• 11.9 Pluristem Therapeutics
  • 11.9.1 Pluristem Therapeutics Company Details
  • 11.9.2 Pluristem Therapeutics Business Overview
  • 11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
  • 11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2016-2021)
  • 11.9.5 Pluristem Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer